Treace Medical Concepts (TMCI)
NASDAQ:TMCI
US Market
Holding TMCI?
Track your performance easily

Treace Medical Concepts (TMCI) Ownership - Who Owns Treace Medical Concepts?

95 Followers

Treace Medical Concepts (TMCI) Ownership Overview

28.98%11.02%9.37%13.63%37.00%
28.98% Insiders
9.37% Other Institutional Investors
13.63% ETFs
37.00% Public Companies and
Individual Investors
The ownership structure of Treace Medical Concepts (TMCI) stock is a mix of institutional, retail, and individual investors. Approximately 34.02% of the company’s stock is owned by Institutional Investors, 28.98% is owned by Insiders, and 37.00% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
John T. Treace
Ceo,director, >10% Owner
xxxxxxxxxxxxx
$265500
Aug 19, 2024
James Treace
Director
xxxxxxxxxxxxx
$500640
Aug 15, 2024
John T. Treace
Ceo,director, >10% Owner
xxxxxxxxxxxxx
$510000
Jun 11, 2024
John T. Treace
Ceo,director, >10% Owner
xxxxxxxxxxxxx
$264600

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,828,211Insider18.90%98,055,869
3,063,708Institution4.92%25,398,139
3,048,480Institution4.89%25,271,899
2,550,663Institution4.09%21,144,996
2,379,507Institution3.82%19,726,113
2,304,954Institution3.70%19,108,069
1,779,624Insider2.86%14,753,083
1,563,064Insider2.51%12,957,801
1,185,914Institution1.90%9,831,227
1,072,944Insider1.72%8,894,706

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,048,480Institution4.89%25,271,899
1,185,914Institution1.90%9,831,227
542,405Institution0.87%4,496,537
526,918Institution0.85%4,368,150
427,077Institution0.69%3,540,468
275,488Institution0.44%2,283,796
246,106Institution0.40%2,040,219
155,185Institution0.25%1,286,484
142,371Institution0.23%1,180,256
52,100Institution0.08%431,909

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,324,272Institution2.13%10,978,215
1,458,503Institution2.34%8,459,317
788,482Institution1.27%6,339,395
788,482Institution1.27%6,339,395
788,482Institution1.27%6,339,395
674,760Institution1.08%3,913,608
436,376Institution0.70%3,617,557
351,662Institution0.56%2,630,349
249,642Institution0.40%2,069,532
216,502Institution0.35%1,740,676

FAQ

Who Owns Treace Medical Concepts (TMCI)?
According to the latest TipRanks data, approximately 9.37% of the company's stock is held by institutional investors, 28.98% is held by insiders, and 37.00% is held by retail investors.
    What percentage of Treace Medical Concepts (TMCI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.37% of Treace Medical Concepts (TMCI) stock is held by institutional investors.
      What percentage of Treace Medical Concepts (TMCI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 37.00% of Treace Medical Concepts (TMCI) stock is held by retail investors.
        Who owns the most shares of Treace Medical Concepts (TMCI)?
        Treace John T. owns the most shares of Treace Medical Concepts (TMCI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis